Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study.
General population
Iron deficiency
Risk factor
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
24
10
2019
accepted:
11
03
2020
pubmed:
28
3
2020
medline:
11
8
2021
entrez:
28
3
2020
Statut:
ppublish
Résumé
Iron deficiency is now accepted as an independent entity beyond anemia. Recently, a new functional definition of iron deficiency was proposed and proved strong efficacy in randomized cardiovascular clinical trials of intravenous iron supplementation. Here, we characterize the impact of iron deficiency on all-cause mortality in the non-anemic general population based on two distinct definitions. The Gutenberg Health Study is a population-based, prospective, single-center cohort study. The 5000 individuals between 35 and 74 years underwent baseline and a planned follow-up visit at year 5. Tested definitions of iron deficiency were (1) functional iron deficiency-ferritin levels below 100 µg/l, or ferritin levels between 100 and 299 µg/l and transferrin saturation below 20%, and (2) absolute iron deficiency-ferritin below 30 µg/l. At baseline, a total of 54.5% of participants showed functional iron deficiency at a mean hemoglobin of 14.3 g/dl; while, the rate of absolute iron deficiency was 11.8%, at a mean hemoglobin level of 13.4 g/dl. At year 5, proportion of newly diagnosed subjects was 18.5% and 4.8%, respectively. Rate of all-cause mortality was 7.2% (n = 361); while, median follow-up was 10.1 years. After adjustment for hemoglobin and major cardiovascular risk factors, the hazard ratio with 95% confidence interval of the association of iron deficiency with mortality was 1.3 (1.0-1.6; p = 0.023) for the functional definition, and 1.9 (1.3-2.8; p = 0.002) for absolute iron deficiency. Iron deficiency is very common in the apparently healthy general population and independently associated with all-cause mortality in the mid to long term.
Sections du résumé
BACKGROUND
BACKGROUND
Iron deficiency is now accepted as an independent entity beyond anemia. Recently, a new functional definition of iron deficiency was proposed and proved strong efficacy in randomized cardiovascular clinical trials of intravenous iron supplementation. Here, we characterize the impact of iron deficiency on all-cause mortality in the non-anemic general population based on two distinct definitions.
METHODS
METHODS
The Gutenberg Health Study is a population-based, prospective, single-center cohort study. The 5000 individuals between 35 and 74 years underwent baseline and a planned follow-up visit at year 5. Tested definitions of iron deficiency were (1) functional iron deficiency-ferritin levels below 100 µg/l, or ferritin levels between 100 and 299 µg/l and transferrin saturation below 20%, and (2) absolute iron deficiency-ferritin below 30 µg/l.
RESULTS
RESULTS
At baseline, a total of 54.5% of participants showed functional iron deficiency at a mean hemoglobin of 14.3 g/dl; while, the rate of absolute iron deficiency was 11.8%, at a mean hemoglobin level of 13.4 g/dl. At year 5, proportion of newly diagnosed subjects was 18.5% and 4.8%, respectively. Rate of all-cause mortality was 7.2% (n = 361); while, median follow-up was 10.1 years. After adjustment for hemoglobin and major cardiovascular risk factors, the hazard ratio with 95% confidence interval of the association of iron deficiency with mortality was 1.3 (1.0-1.6; p = 0.023) for the functional definition, and 1.9 (1.3-2.8; p = 0.002) for absolute iron deficiency.
CONCLUSIONS
CONCLUSIONS
Iron deficiency is very common in the apparently healthy general population and independently associated with all-cause mortality in the mid to long term.
Identifiants
pubmed: 32215702
doi: 10.1007/s00392-020-01631-y
pii: 10.1007/s00392-020-01631-y
pmc: PMC7588396
doi:
Substances chimiques
Biomarkers
0
Hemoglobins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1352-1357Subventions
Organisme : Stiftung Rheinland-Pfalz für Innovation
ID : AZ 961-386261/733
Références
Lancet. 2016 Feb 27;387(10021):907-16
pubmed: 26314490
Biochim Biophys Acta. 2012 Mar;1820(3):188-202
pubmed: 22085723
Cell Metab. 2010 Aug 4;12(2):194-201
pubmed: 20674864
Biometrics. 2011 Dec;67(4):1406-13
pubmed: 21627630
Eur J Intern Med. 2018 Jun;52:1-7
pubmed: 29680173
Nat Rev Cardiol. 2015 Nov;12(11):659-69
pubmed: 26194551
N Engl J Med. 2005 Mar 10;352(10):1011-23
pubmed: 15758012
Cell. 2010 Jul 9;142(1):24-38
pubmed: 20603012
Biomolecules. 2018 Jun 28;8(3):
pubmed: 29958400
Biomolecules. 2018 Jul 20;8(3):
pubmed: 30037035
N Engl J Med. 2009 Dec 17;361(25):2436-48
pubmed: 19920054
N Engl J Med. 2015 May 7;372(19):1832-43
pubmed: 25946282
Eur J Haematol. 2016 Jun;96(6):618-28
pubmed: 26256281
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Jun;55(6-7):824-9
pubmed: 22736163
Biomolecules. 2018 Aug 09;8(3):
pubmed: 30096922
Eur Heart J. 2015 Mar 14;36(11):657-68
pubmed: 25176939